antiretroviral therapy
Daily Statin Reduces CV Events by 35% Among Adults With HIV
The risk for CVD in people living with HIV can be 50% to 100% greater than those without HIV.
AUGUST 8, 2023
Sometimes Even ‘Detectable’ Can Mean Untransmissible
People living with HIV who maintain low—but still detectible—levels of the virus but adhere to their ...
JULY 25, 2023
New Paradigms in HIV Therapy
Near the end of the first act of Jonathan Larson’s iconic musical “Rent,” which opened on ...
JUNE 23, 2022
‘Things Can Go Downhill’ From Med Errors for Patients With HIV
Errors related to antiretroviral therapy among hospitalized patients with HIV can have a significant long-term ...
MAY 20, 2022
FDA Approves Symtuza, the First Complete Darunavir-Based, Single-Tablet Regimen for HIV
The FDA recently approved Janssen's Symtuza, the first complete darunavir-based, single-tablet regimen for the ...
JULY 19, 2018
FDA Approves Simfi Triple Combo HIV Therapy
A new triple combo therapy will be available in the United States that Mylan says will be priced lower than other ...
MARCH 30, 2018
Investigational ART Efficacious, Well Tolerated
Doravirine (Merck), a late-stage investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), was found ...
MARCH 9, 2018
Switching HIV Regimen Found Safe
Switching to the newly approved Biktarvy in virologically suppressed adults maintained viral suppression with fewer ...
MARCH 7, 2018
FDA Approves Juluca, First 2-Drug Regimen for HIV
Juluca is the first complete treatment regimen containing only two drugs for the maintenance treatment of HIV-1 ...
NOVEMBER 22, 2017
New Data Support TAF Switch in HIV
A subanalysis of the phase 3 Study 109 supports switching HIV patients who are virologically suppressed from a ...
OCTOBER 18, 2017
Bictegravir-Containing Compound Looks Promising for HIV
Bictegravir is a novel, potent integrase strand transfer inhibitor (INSTI), which features a high in vitro barrier ...
OCTOBER 10, 2017
Vitamin D3 Increases Bone Density in HIV Patients
Regular vitamin D3 supplementation can counteract one side effect of ART—loss of bone density.
SEPTEMBER 7, 2017
